Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Infant Bacterial Therapeutics AB
AB
Active
Org 5568738586
Katarina Bangata 70, 116 42
Stockholm
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2011
10-19 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Infant Bacterial Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
SS
Staffan Strömberg
Chief Executive Officer
Chief Executive Officer
2020
JM
Jenny Matilda Holmgren
Chief Auditor
Chief Auditor
2022
Former (1)
EB
Elsa Birgitta Lööf
Chief Auditor
Chief Auditor
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
PM
Peter Michael Rothschild
Chairman
2020
AK
Anna Kristina Sjöblom Nygren
Board of Directors
2020
KM
Karin Margareta Hagman
Board of Directors
2020
EE
Eva Elisabeth Idén
Board of Directors
2020
OA
Olof Anthon Jahreskog
Board of Directors
2020
Former (1)
RM
Robert Molander
Board of Directors
2022 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Infant Bacterial Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
